Goldman Sachs’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $133M | Buy |
250,781
+82,294
| +49% | +$38M | 0.01% | 1015 |
|
|
2026
Q1 | $80.9M | Sell |
168,487
-178,562
| -51% | -$91.4M | 0.01% | 1194 |
|
|
2025
Q4 | $195M | Buy |
347,049
+166,654
| +92% | +$94.6M | 0.02% | 648 |
|
|
2025
Q3 | $92.8M | Buy |
180,395
+82,719
| +85% | +$36.1M | 0.01% | 993 |
|
|
2025
Q2 | $30.7M | Sell |
97,676
-184,546
| -65% | -$55.4M | ﹤0.01% | 1732 |
|
|
2025
Q1 | $86M | Sell |
282,222
-159,008
| -36% | -$53.5M | 0.01% | 860 |
|
|
2024
Q4 | $147M | Sell |
441,230
-45,213
| -9% | -$15.3M | 0.02% | 622 |
|
|
2024
Q3 | $162M | Sell |
486,443
-188,114
| -28% | -$71.5M | 0.03% | 592 |
|
|
2024
Q2 | $278M | Buy |
674,557
+146,139
| +28% | +$57.9M | 0.05% | 404 |
|
|
2024
Q1 | $214M | Buy |
528,418
+157,263
| +42% | +$55.3M | 0.04% | 469 |
|
|
2023
Q4 | $114M | Sell |
371,155
-28,935
| -7% | -$7.81M | 0.02% | 719 |
|
|
2023
Q3 | $96.9M | Buy |
400,090
+3,945
| +1% | +$1.01M | 0.02% | 736 |
|
|
2023
Q2 | $95.1M | Sell |
396,145
-152,583
| -28% | -$31.7M | 0.02% | 731 |
|
|
2023
Q1 | $103M | Buy |
548,728
+162,444
| +42% | +$33.6M | 0.02% | 688 |
|
|
2022
Q4 | $82.1M | Sell |
386,284
-52,018
| -12% | -$10.4M | 0.02% | 831 |
|
|
2022
Q3 | $68.9M | Buy |
438,302
+48,264
| +12% | +$7.7M | 0.02% | 886 |
|
|
2022
Q2 | $58.4M | Buy |
390,038
+95,524
| +32% | +$13.8M | 0.01% | 1011 |
|
|
2022
Q1 | $48.2M | Sell |
294,514
-24,199
| -8% | -$3.99M | 0.01% | 1303 |
|
|
2021
Q4 | $69.4M | Buy |
318,713
+69,066
| +28% | +$14.5M | 0.01% | 1067 |
|
|
2021
Q3 | $47.3M | Sell |
249,647
-36,023
| -13% | -$6.57M | 0.01% | 1329 |
|
|
2021
Q2 | $50.5M | Buy |
285,670
+53,873
| +23% | +$9.3M | 0.01% | 1246 |
|
|
2021
Q1 | $38M | Buy |
231,797
+88,605
| +62% | +$13.6M | 0.01% | 1389 |
|
|
2020
Q4 | $19.9M | Buy |
143,192
+29,322
| +26% | +$3.7M | 0.01% | 1856 |
|
|
2020
Q3 | $12.7M | Sell |
113,870
-209,968
| -65% | -$24.3M | ﹤0.01% | 2108 |
|
|
2020
Q2 | $30.1M | Sell |
323,838
-27,640
| -8% | -$2.35M | 0.01% | 1349 |
|
|
2020
Q1 | $25.8M | Sell |
351,478
-48,484
| -12% | -$4.21M | 0.01% | 1333 |
|
|
2019
Q4 | $33.6M | Sell |
399,962
-96,061
| -19% | -$7.43M | 0.01% | 1439 |
|
|
2019
Q3 | $41.7M | Buy |
496,023
+127,033
| +34% | +$9.6M | 0.01% | 1226 |
|
|
2019
Q2 | $24.1M | Sell |
368,990
-84,565
| -19% | -$4.87M | 0.01% | 1707 |
|
|
2019
Q1 | $26.7M | Buy |
453,555
+17,230
| +4% | +$1.03M | 0.01% | 1624 |
|
|
2018
Q4 | $23.1M | Buy |
436,325
+20,125
| +5% | +$1.1M | 0.01% | 1697 |
|
|
2018
Q3 | $24.9M | Buy |
416,200
+317,865
| +323% | +$17.4M | 0.01% | 1759 |
|
|
2018
Q2 | $4.23M | Buy |
98,335
+56,673
| +136% | +$2.29M | ﹤0.01% | 3070 |
|
|
2018
Q1 | $1.45M | Sell |
41,662
-6,718
| -14% | -$245K | ﹤0.01% | 3803 |
|
|
2017
Q4 | $1.75M | Buy |
48,380
+3,761
| +8% | +$132K | ﹤0.01% | 3893 |
|
|
2017
Q3 | $1.42M | Buy |
44,619
+9,929
| +29% | +$303K | ﹤0.01% | 4278 |
|
|
2017
Q2 | $1.01M | Buy |
34,690
+482
| +1% | +$13.5K | ﹤0.01% | 4449 |
|
|
2017
Q1 | $1.02M | Buy |
34,208
+28,487
| +498% | +$919K | ﹤0.01% | 4358 |
|
|
2016
Q4 | $206K | Sell |
5,721
-11,349
| -66% | -$378K | ﹤0.01% | 5747 |
|
|
2016
Q3 | $510K | Buy |
+17,070
| New | +$498K | ﹤0.01% | 5028 |
|
Other funds holding MEDP
WA
Goldman Sachs's MEDP Position: Q2 2026 in Review
Goldman Sachs increased its Medpace (MEDP) stake by 49% in Q2 2026, buying an estimated $38M and bringing the position to 250,781 shares worth $133M. The position accounts for 0.01% of the portfolio, ranked #1015.
Goldman Sachs first reported a position in MEDP in Q3 2016 and has held it in 40 quarters since. The position peaked at $278M in Q2 2024. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Goldman Sachs held 250,781 shares of Medpace worth $133M as of Q2 2026.
- Goldman Sachs bought 82,294 Medpace shares in Q2 2026, an estimated $38M.
- Medpace made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1015 holding.
- Goldman Sachs first reported a position in Medpace in Q3 2016 and has held it in 40 quarters since.
- Goldman Sachs's Medpace position peaked at $278M in Q2 2024.
- 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.